June 19, 2019

Dana-Farber Cancer Institute v. Ono Pharmaceutical Co., Ltd.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 16, 2020

    Full Fed. Circ. Won't Review Inventorship Row Over Cancer IP

    The full Federal Circuit Friday rejected a bid from Bristol-Meyers and others for review of a panel decision that two American scientists from the Dana-Farber Cancer Institute should be named as co-inventors on six patents involved in Nobel Prize-winning cancer research.

4 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login